Lexaria Bioscience Corp. (LEXX)

Lexaria Bioscience Ratios and Metrics

Market cap in millions USD. Fiscal year is September - August.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 7, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021	Aug 31, 2020	Aug 31, 2019
Market Capitalization	40	8	18	35	31	54
Market Cap Growth	733.96%	-51.77%	-50.18%	13.53%	-42.60%	-63.99%
Enterprise Value	29	5	10	27	29	52
Last Close Price	2.19	1.05	2.96	6.22	10.38	20.70
PE Ratio	-	-1.04	-2.40	-6.78	-7.31	-13.09
PS Ratio	55.86	37.56	68.97	48.92	98.93	243.74
PB Ratio	3.42	3.17	2.31	2.71	12.55	21.78
P/FCF Ratio	-10.69	-1.44	-3.57	-8.86	-11.89	-14.86
P/OCF Ratio	-10.69	-1.44	-3.61	-8.86	-11.89	-18.05
EV/Sales Ratio	71.73	21.58	39.44	37.19	92.55	235.09
EV/EBITDA Ratio	-9.95	-0.76	-1.55	-4.82	-7.22	-13.32
EV/EBIT Ratio	-9.67	-0.75	-1.52	-4.73	-7.02	-13.11
EV/FCF Ratio	-9.62	-0.83	-2.04	-6.74	-11.13	-14.33
Debt / Equity Ratio	0.01	0.06	0.01	0.01	0.06	-
Debt / FCF Ratio	-0.03	-0.03	-0.01	-0.02	-0.06	-
Asset Turnover	0.05	0.04	0.02	0.09	0.11	0.09
Inventory Turnover	-	-	2.11	2.39	0.81	0.28
Quick Ratio	55.84	6.17	32.79	78.90	7.20	8.79
Current Ratio	58.27	8.22	35.96	81.18	8.53	9.86
Return on Equity (ROE)	-70.66%	-130.18%	-71.35%	-73.16%	-166.85%	-170.47%
Return on Assets (ROA)	-38.21%	-74.81%	-39.21%	-44.17%	-94.23%	-97.68%
Return on Capital (ROIC)	-41.33%	-77.59%	-39.70%	-44.99%	-101.11%	-102.25%
Earnings Yield	-11.98%	-78.45%	-41.27%	-11.39%	-12.63%	-7.56%
FCF Yield	-11.58%	-69.63%	-27.98%	-11.28%	-8.41%	-6.73%
Buyback Yield / Dilution	-72.56%	-12.38%	-34.02%	-58.34%	-6.95%	-9.63%
Total Shareholder Return	-72.56%	-12.38%	-34.02%	-58.34%	-6.95%	-9.63%

Source: S&P Capital IQ. Standard template. Financial Sources.